Some animal studies showed that angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor blockers (ARB) increase the ACE2, creating the hypothesis that these drugs could facilitate the inoculation of SARS-CoV-2 potentially leading to a higher risk of infection and/or disease severity [3]. The gene discussed is ACE; the disease is infection.